BHAVINKUMAR BHAGAT: Open Payments
NPI 1275992992 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 25 payments from 10 companies in 2025. Trend: 2023 $143 · 2024 $62 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $156 |
| Actelion Pharmaceuticals US, Inc. | 3 | $83 |
| Novo Nordisk Inc | 2 | $56 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| PFIZER INC. | 1 | $35 |
| CVRx, Inc. | 1 | $32 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: LEQVIO, UPTRAVI, VERQUVO, LifeVest, ELIQUIS, Ozempic, Barostim Neo System, Wegovy.
Industry payments across FL — which companies pay providers there.
